Systemic inflammation and priming of peripheral blood leukocytes persist during clinical remission in horses with heaves

Veterinary Immunology and Immunopathology

Volumn 146, Issue 1, 2012, Pages 35-45

  Lavoie Lamoureux, Anouk ^a   Beauchamp, Guy ^a   Quessy, Sylvain ^a   Martin, James G ^b   Lavoie, Jean Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Heaves; Innate immunity; Neutrophils; Pro inflammatory cytokines; Systemic inflammation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CELL POPULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; HEAVE; HORSE; HORSE DISEASE; INNATE IMMUNITY; LEUKOCYTE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; REMISSION; TH1 CELL; TH2 CELL;

ANIMALS; BRONCHOCONSTRICTION; CELLS, CULTURED; HORSE DISEASES; HORSES; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; NEUTROPHILS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE;

EID: 84862832775     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.01.020     Document Type: Article

References (65)

1. Ainsworth D.M., Grunig G., Matychak M.B., Young J., Wagner B., Erb H.N., Antczak D.F. Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells. Vet. Immunol. Immunopathol. 2003, 96:83-91.
2. Ainsworth D.M., Wagner B., Franchini M., Grunig G., Erb H.N., Tan J.Y. Time-dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with recurrent airway obstruction. Am. J. Vet. Res. 2006, 67:669-677.
3. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25:187-191.
4. Baines K.J., Simpson J.L., Bowden N.A., Scott R.J., Gibson P.G. Differential gene expression and cytokine production from neutrophils in asthma phenotypes. Eur. Respir. J. 2010, 35:522-531.
5. Barnes P.J. Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev. 2003, 14:511-522.
6. Bettiol J., Bartsch P., Louis R., De Groote D., Gevaerts Y., Louis E., Malaise M. Cytokine production from peripheral whole blood in atopic and nonatopic asthmatics: relationship with blood and sputum eosinophilia and serum IgE levels. Allergy 2000, 55:1134-1141.
7. Borges V.M., Vandivier R.W., McPhillips K.A., Kench J.A., Morimoto K., Groshong S.D., Richens T.R., Graham B.B., Muldrow A.M., Van Heule L., Henson P.M., Janssen W.J. TNFalpha inhibits apoptotic cell clearance in the lung, exacerbating acute inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L586-L595.
8. Brazil T.J., Dagleish M.P., McGorum B.C., Dixon P.M., Haslett C., Chilvers E.R. Kinetics of pulmonary neutrophil recruitment and clearance in a natural and spontaneously resolving model of airway inflammation. Clin. Exp. Allergy 2005, 35:854-865.
9. Brazil T.J., Rossi A.G., Haslett C., McGorum B., Dixon P.M., Chilvers E.R. Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils. J. Leukoc. Biol. 1998, 63:380-388.
10. Bureau F., Delhalle S., Bonizzi G., Fievez L., Dogne S., Kirschvink N., Vanderplasschen A., Merville M.P., Bours V., Lekeux P. Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. J. Immunol. 2000, 165:5822-5830.
11. Cassatella M.A. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 1995, 16:21-26.
12. Chen L.W., Huang H.L., Lee I.T., Hsu C.M., Lu P.J. Thermal injury-induced priming effect of neutrophil is TNF-alpha and P38 dependent. Shock 2006, 26:69-76.
13. Chun E., Lee S.H., Lee S.Y., Shim E.J., Cho S.H., Min K.U., Kim Y.Y., Park H.W. Toll-like receptor expression on peripheral blood mononuclear cells in asthmatics; implications for asthma management. J. Clin. Immunol. 2010, 30:459-464.
14. Colotta F., Re F., Polentarutti N., Sozzani S., Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992, 80:2012-2020.
15. Cowburn A.S., Deighton J., Walmsley S.R., Chilvers E.R. The survival effect of TNF-alpha in human neutrophils is mediated via NF-kappa B-dependent IL-8 release. Eur. J. Immunol. 2004, 34:1733-1743.
16. Deans C., Wigmore S.J. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr. Opin. Clin. Nutr. Metab. Care 2005, 8:265-269.
17. Debrue M., Hamilton E., Joubert P., Lajoie-Kadoch S., Lavoie J.P. Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells. Vet. Immunol. Immunopathol. 2005, 105:25-31.
18. Eder C., Curik I., Brem G., Crameri R., Bodo I., Habe F., Lazary S., Solkner J., Marti E. Influence of environmental and genetic factors on allergen-specific immunoglobulin-E levels in sera from Lipizzan horses. Equine Vet. J. 2001, 33:714-720.
19. Eder W., Klimecki W., Yu L., von Mutius E., Riedler J., Braun-Fahrlander C., Nowak D., Martinez F.D. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J. Allergy Clin. Immunol. 2004, 113:482-488.
20. Fageras Bottcher M., Hmani-Aifa M., Lindstrom A., Jenmalm M.C., Mai X.M., Nilsson L., Zdolsek H.A., Bjorksten B., Soderkvist P., Vaarala O. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J. Allergy Clin. Immunol. 2004, 114:561-567.
21. Franchini M., Gill U., von Fellenberg R., Bracher V.D. Interleukin-8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay. Am. J. Vet. Res. 2000, 61:1369-1374.
22. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59:574-580.
23. Giguere S., Prescott J.F. Quantitation of equine cytokine mRNA expression by reverse transcription-competitive polymerase chain reaction. Vet. Immunol. Immunopathol. 1999, 67:1-15.
24. Giguere S., Viel L., Lee E., MacKay R.J., Hernandez J., Franchini M. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Vet. Immunol. Immunopathol. 2002, 85:147-158.
25. Hackett T.L., Holloway R., Holgate S.T., Warner J.A. Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study. Respir. Res. 2008, 9:47.
26. Halliwell R.E., McGorum B.C., Irving P., Dixon P.M. Local and systemic antibody production in horses affected with chronic obstructive pulmonary disease. Vet. Immunol. Immunopathol. 1993, 38:201-215.
27. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am. J. Respir. Crit. Care Med. 1999, 160:S5-S11.
28. Higashimoto Y., Yamagata Y., Taya S., Iwata T., Okada M., Ishiguchi T., Sato H., Itoh H. Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences. Respirology 2008, 13:128-133.
29. Horohov D.W., Beadle R.E., Mouch S., Pourciau S.S. Temporal regulation of cytokine mRNA expression in equine recurrent airway obstruction. Vet. Immunol. Immunopathol. 2005, 108:237-245.
30. Huang H., Lavoie-Lamoureux A., Moran K., Lavoie J.P. IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 292:L1147-1154.
31. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
32. Joubert P., Cordeau M.E., Boyer A., Silversides D.W., Lavoie J.P. Cytokine expression by peripheral blood neutrophils from heaves-affected horses before and after allergen challenge. Vet. J. 2008, 178:227-232.
33. Joubert P., Silversides D.W., Lavoie J.P. Equine neutrophils express mRNA for tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, macrophage-inflammatory-protein-2 but not for IL-4, IL-5 and interferon-gamma. Equine Vet. J. 2001, 33:730-733.
34. Keel M., Ungethum U., Steckholzer U., Niederer E., Hartung T., Trentz O., Ertel W. Interleukin-10 counter regulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997, 90:3356-3363.
35. Kilpatrick L.E., Sun S., Mackie D., Baik F., Li H., Korchak H.M. Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of delta-PKC and ERK1/2. J. Leukoc. Biol. 2006, 80:1512-1521.
36. Laan T.T., Bull S., Pirie R., Fink-Gremmels J. The role of alveolar macrophages in the pathogenesis of recurrent airway obstruction in horses. J. Vet. Intern. Med. 2006, 20:167-174.
37. Lachheb J., Dhifallah I.B., Chelbi H., Hamzaoui K., Hamzaoui A. Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children. Tissue Antigens 2008, 71:417-425.
38. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Phillips R.S., Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol. Cell. Biol. 1999, 19:4311-4323.
39. Lavoie-Lamoureux A., Maghni K., Lavoie J.P. Optimization of a procedure to accurately detect equine TNFalpha in serum samples. Vet. Immunol. Immunopathol. 2010, 138:118-123.
40. Lavoie-Lamoureux A., Moran K., Beauchamp G., Mauel S., Steinbach F., Lefebvre-Lavoie J., Martin J.G., Lavoie J.P. IL-4 activates equine neutrophils and induces a mixed inflammatory cytokine expression profile with enhanced neutrophil chemotactic mediator release ex vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 299:472-482.
41. Lavoie J.P., Maghni K., Desnoyers M., Taha R., Martin J.G., Hamid Q.A. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am. J. Respir. Crit. Care Med. 2001, 164:1410-1413.
42. Leclere M., Lavoie-Lamoureux A., Gelinas-Lymburner E., David F., Martin J.G., Lavoie J.P. Effect of antigenic exposure on airway smooth muscle remodeling in an equine model of chronic asthma. Am. J. Respir. Cell Mol. Biol. 2011, 45:181-187.
43. Luo H.R., Loison F. Constitutive neutrophil apoptosis: mechanisms and regulation. Am. J. Hematol. 2008, 83:288-295.
44. Marr K.A., Foster A.P., Lees P., Cunningham F.M., Page C.P. Effect of antigen challenge on the activation of peripheral blood neutrophils from horses with chronic obstructive pulmonary disease. Res. Vet. Sci. 1997, 62:253-260.
45. Marr K.A., Lees P., Cunningham F.M. Antigen challenge increases adherence of circulating neutrophils in horses with chronic obstructive pulmonary disease. Equine Vet. J. 2002, 34:65-70.
46. Marti E., Gerber H., Essich G., Oulehla J., Lazary S. The genetic basis of equine allergic diseases. 1. Chronic hypersensitivity bronchitis. Equine Vet. J. 1991, 23:457-460.
47. McGorum B.C., Dixon P.M., Halliwell R.E. Phenotypic analysis of peripheral blood and bronchoalveolar lavage fluid lymphocytes in control and chronic obstructive pulmonary disease affected horses, before and after 'natural (hay and straw) challenges'. Vet. Immunol. Immunopathol. 1993, 36:207-222.
48. Nevalainen M., Raulo S.M., Brazil T.J., Pirie R.S., Sorsa T., McGorum B.C., Maisi P. Inhalation of organic dusts and lipopolysaccharide increases gelatinolytic matrix metalloproteinases (MMPs) in the lungs of heaves horses. Equine Vet. J. 2002, 34:150-155.
49. Niederau C., Backmerhoff F., Schumacher B. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Hepatogastroenterology 1997, 44:90-107.
50. Park H.S., Park J.Y., Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res. Clin. Pract. 2005, 69:29-35.
51. Pirie R.S., Collie D.D., Dixon P.M., McGorum B.C. Inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects in equine heaves (organic dust-induced asthma). Clin. Exp. Allergy 2003, 33:676-683.
52. Pirie R.S., Dixon P.M., Collie D.D., McGorum B.C. Pulmonary and systemic effects of inhaled endotoxin in control and heaves horses. Equine Vet. J. 2001, 33:311-318.
53. Pirie R.S., Dixon P.M., McGorum B.C. Endotoxin contamination contributes to the pulmonary inflammatory and functional response to Aspergillus fumigatus extract inhalation in heaves horses. Clin. Exp. Allergy 2003, 33:1289-1296.
54. Robinson N. International workshop on equine chronic airway disease. Michigan State University 16-18 June 2000. Equine Vet. J. 2001, 33:5-19.
55. Robinson N.E., Olszewski M.A., Boehler D., Berney C., Hakala J., Matson C., Derksen F.J. Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial. Equine Vet. J. 2000, 32:393-400.
56. Schmallenbach K.H., Rahman I., Sasse H.H., Dixon P.M., Halliwell R.E., McGorum B.C., Crameri R., Miller H.R. Studies on pulmonary and systemic Aspergillus fumigatus-specific IgE and IgG antibodies in horses affected with chronic obstructive pulmonary disease (COPD). Vet. Immunol. Immunopathol. 1998, 66:245-256.
57. Seko Y., Cole S., Kasprzak W., Shapiro B.A., Ragheb J.A. The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun. Rev. 2006, 5:299-305.
58. Simonen-Jokinen T., Pirie R.S., McGorum B., Maisi P. Dose responses to inhalation of endotoxin, hay dust suspension and Aspergillus fumigatus extract in horses as measured by levels and activation of matrix metalloproteinase-9. Equine Vet. J. 2005, 37:155-160.
59. Simpson J.L., Grissell T.V., Douwes J., Scott R.J., Boyle M.J., Gibson P.G. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 2007, 62:211-218.
60. Snow M.H., Mikuls T.R. Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Curr. Opin. Rheumatol. 2005, 17:234-241.
61. Vercelli D. Gene-environment interactions in asthma and allergy: the end of the beginning?. Curr. Opin. Allergy Clin. Immunol. 2010, 10:145-148.
62. Vick M.M., Adams A.A., Murphy B.A., Sessions D.R., Horohov D.W., Cook R.F., Shelton B.J., Fitzgerald B.P. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J. Anim. Sci. 2007, 85:1144-1155.
63. Vychodilova-Krenkova L., Matiasovic J., Horin P. Single nucleotide polymorphisms in four functionally related immune response genes in the horse: CD14, TLR4, Cepsilon, and Fcepsilon R1 alpha. Int. J. Immunogenet. 2005, 32:277-283.
64. Weiss D.J., Evanson O.A. Evaluation of lipopolysaccharide-induced activation of equine neutrophils. Am. J. Vet. Res. 2002, 63:811-815.
65. Werners A.H., Bull S., Vendrig J.C., Smyth T., Bosch R.R., Fink-Gremmels J., Bryant C.E. Genotyping of Toll-like receptor 4, myeloid differentiation factor 2 and CD-14 in the horse: an investigation into the influence of genetic polymorphisms on the LPS induced TNF-alpha response in equine whole blood. Vet. Immunol. Immunopathol. 2006, 111:165-173.